Srinivas Tantravahi, MBBS; MRCP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    karyopharm therapeutics
    Topic:
    Consulting/Advisory Board/Research support
    Date added:
    09/27/2021
    Date updated:
    08/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Consulting/Advisory Board
    Date added:
    09/27/2021
    Date updated:
    08/31/2023
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Topic:
    Consulting/Advisory Board
    Date added:
    08/31/2023
    Date updated:
    08/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    CTI BioPharma
    Topic:
    Consulting/Advisory Board
    Date added:
    08/31/2023
    Date updated:
    08/31/2023
  • Type of financial relationship:
    Professional Services
    Ineligible company:
    MorphoSys
    Topic:
    Consulting/Advisory Board
    Date added:
    08/31/2023
    Date updated:
    08/31/2023
Return to Summit on Cancer Health Disparities (SCHD24)